Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Canine IL-1 beta/IL-1F2 Biotinylated Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems BAF3747
This item is not returnable.
View return policy
Description
IL-1 beta/IL-1F2 Polyclonal specifically detects IL-1 beta/IL-1F2 in Canine samples. It is validated for Western Blot, Intracellular Staining by Flow Cytometry.Specifications
| IL-1 beta/IL-1F2 | |
| Polyclonal | |
| Biotin | |
| Q28292 | |
| IL1B | |
| E. coli-derived recombinant canine IL-1 beta/IL-1F2 Asp114-Ser265 Accession # Q28292 | |
| 50 μg | |
| Primary | |
| Detects canine IL-1 beta/IL-1F2 in Western blots. In Western blots, approximately 40% cross-reactivity with recombinant feline IL-1 beta is observed, 10% cross-reactivity with recombinant human IL-1 beta , recombinant rhesus macaque IL-1 beta , recombinant equine IL-1 beta , and recombinant porcine IL-1 beta is observed, and 5% cross-reactivity with recombinant mouse IL-1 beta , recombinant rat IL-1 beta , and recombinant cotton rat IL-1 beta is observed. | |
| Canine | |
| IgG |
| Western Blot, Flow Cytometry | |
| LYOPH | |
| Western Blot 0.1 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells | |
| catabolin, IL-1, IL1 beta, IL-1 beta, IL-1b, IL1B, IL1-BETA, IL-1F2, IL1F2IL-1 beta, interleukin 1, beta, interleukin-1 beta, preinterleukin 1 beta, pro-interleukin-1-beta | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 3553 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction